NASDAQ · CTY
City Therapeutics short interest
$20.88+0.82%
Close Nov 2, 2026 · split-adjustedShares short21.3KSettled Nov 30, 2020
Change−65.5%from 61.6K
% of float0.0%Float 45.9M shares
Days to cover1.0Short volume 76.4% (10d)
Shares sold short by settlement
Settlement history
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| Nov 30, 2020 | 21.3K | −65.5% | 1.0 |
| Nov 13, 2020 | 61.6K | −25.0% | 1.9 |
| Oct 30, 2020 | 82.1K | +27.3% | 2.0 |
| Oct 15, 2020 | 64.5K | −9.6% | 1.7 |
| Sep 30, 2020 | 71.3K | +11.9% | 1.2 |
| Sep 15, 2020 | 63.7K | +277.7% | 1.2 |
| Aug 31, 2020 | 16.9K | −10.6% | 1.0 |
| Aug 14, 2020 | 18.9K | +49.6% | 1.0 |
| Jul 31, 2020 | 12.6K | +3.9% | 1.0 |
| Jul 15, 2020 | 12.2K | −16.5% | 1.0 |
| Jun 30, 2020 | 14.6K | +24.5% | 1.0 |
| Jun 15, 2020 | 11.7K | — | 1.0 |
Reading these numbers
Short interest is the number of shares sold short and not yet repurchased, reported by FINRA twice a month with a delay of about two weeks. As a share of float it shows how crowded the bet against City Therapeutics is — 0.0% here; days to cover estimates how long buying those shares back would take at average volume. Compare it with the short squeeze monitor or learn more in our short interest guide.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology